Literature DB >> 19729858

Sex/gender medicine. The biological basis for personalized care in cardiovascular medicine.

Faisal A Arain1, Fatima H Kuniyoshi, Ahmed D Abdalrhim, Virginia M Miller.   

Abstract

Sex differences in morbidity and mortality associated with cardiovascular disease have been recognized by the medical community for decades. Investigation into the underlying biological basis of these differences was largely neglected by the scientific community until a report released by the Institute of Medicine in the United States in 2001 "Exploring the Biological Contributions to Human Health: Does Sex Matter?" Recommendations from this report included the need for more accurate use of the terms "sex" and "gender", better tools and resources to study the biological basis of sex differences, integration of findings from different levels of biological organization and continued synergy between basic and clinical researchers. Ten years after the Institute's report, this review evaluates some of the sex differences in cardiovascular disease, reviews new approaches to study sex differences and emphasizes areas where further research is required. In the era of personalized medicine, the study of the biological basis of sex differences promises to optimize preventive, diagnostic and therapeutic strategies for cardiovascular disease in men and women, but will require diligence by the scientific and medical communities to remember that sex does matter.

Entities:  

Mesh:

Year:  2009        PMID: 19729858      PMCID: PMC2941262          DOI: 10.1253/circj.cj-09-0588

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  131 in total

Review 1.  Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen.

Authors:  Vera Regitz-Zagrosek; Elke Lehmkuhl
Journal:  Herz       Date:  2005-08       Impact factor: 1.443

2.  Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Authors:  H N Hodis; W J Mack; R A Lobo; D Shoupe; A Sevanian; P R Mahrer; R H Selzer; C R Liu Cr; C H Liu Ch; S P Azen
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

3.  Sex differences in the effectiveness of statins after myocardial infarction.

Authors:  Igor Karp; Shun-Fu Chen; Louise Pilote
Journal:  CMAJ       Date:  2007-01-30       Impact factor: 8.262

Review 4.  Gender aspects in heart failure. Pathophysiology and medical therapy.

Authors:  V Regitz-Zagrosek; E Lehmkuhl; H B Lehmkuhl; R Hetzer
Journal:  Arch Mal Coeur Vaiss       Date:  2004-09

5.  Gender differences and endothelium- and platelet-derived factors in the coronary circulation.

Authors:  V M Miller; D A Lewis; D A Barber
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-02       Impact factor: 2.557

Review 6.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.

Authors:  A Farb; A P Burke; A L Tang; T Y Liang; P Mannan; J Smialek; R Virmani
Journal:  Circulation       Date:  1996-04-01       Impact factor: 29.690

7.  XIAP regulates intracellular ROS by enhancing antioxidant gene expression.

Authors:  Ulrike Resch; Yvonne M Schichl; Susanne Sattler; Rainer de Martin
Journal:  Biochem Biophys Res Commun       Date:  2008-08-08       Impact factor: 3.575

8.  Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria.

Authors:  Junji Kobayashi; Kouji Nishimura; Munetoshi Matoba; Nobumasa Maekawa; Hiroshi Mabuchi
Journal:  Circ J       Date:  2007-11       Impact factor: 2.993

9.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

Review 10.  Prophylactic oophorectomy in premenopausal women and long-term health.

Authors:  Lynne T Shuster; Bobbie S Gostout; Brandon R Grossardt; Walter A Rocca
Journal:  Menopause Int       Date:  2008-09
View more
  20 in total

1.  Science & gender: vision and mission.

Authors:  Alexandra Kautzky-Willer
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

2.  Exercise vasodilation is greater in women: contributions of nitric oxide synthase and cyclooxygenase.

Authors:  J Mikhail Kellawan; Rebecca E Johansson; John W Harrell; Joshua J Sebranek; Benjamin J Walker; Marlowe W Eldridge; William G Schrage
Journal:  Eur J Appl Physiol       Date:  2015-03-28       Impact factor: 3.078

Review 3.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

Review 4.  Sex steroid signaling: implications for lung diseases.

Authors:  Venkatachalem Sathish; Yvette N Martin; Y S Prakash
Journal:  Pharmacol Ther       Date:  2015-01-14       Impact factor: 12.310

5.  Sex differences in the central and peripheral manifestations of ischemia-induced heart failure in rats.

Authors:  Yang Yu; Shun-Guang Wei; Robert M Weiss; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-05       Impact factor: 4.733

Review 6.  Hypertension: what's sex got to do with it?

Authors:  Margaret A Zimmerman; Jennifer C Sullivan
Journal:  Physiology (Bethesda)       Date:  2013-07

7.  Sex-Steroid Signaling in Lung Diseases and Inflammation.

Authors:  Nilesh Sudhakar Ambhore; Rama Satyanarayana Raju Kalidhindi; Venkatachalem Sathish
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Women with hypertrophic cardiomyopathy have worse survival.

Authors:  Jeffrey B Geske; Kevin C Ong; Konstantinos C Siontis; Virginia B Hebl; Michael J Ackerman; David O Hodge; Virginia M Miller; Rick A Nishimura; Jae K Oh; Hartzell V Schaff; Bernard J Gersh; Steve R Ommen
Journal:  Eur Heart J       Date:  2017-12-07       Impact factor: 29.983

9.  Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.

Authors:  Virginia M Miller; Vesna D Garovic; Kejal Kantarci; Jill N Barnes; Muthuvel Jayachandran; Michelle M Mielke; Michael J Joyner; Lynne T Shuster; Walter A Rocca
Journal:  Biol Sex Differ       Date:  2013-03-28       Impact factor: 5.027

10.  NOS inhibition enhances myogenic tone by increasing rho-kinase mediated Ca2+ sensitivity in the male but not the female gerbil spiral modiolar artery.

Authors:  Katrin Reimann; Gayathri Krishnamoorthy; Philine Wangemann
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.